ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Dogwood Therapeutics Inc

Dogwood Therapeutics Inc (DWTX)

2.20
0.00
(0.00%)
Closed January 16 3:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.20
Bid
1.93
Ask
2.32
Volume
-
0.00 Day's Range 0.00
1.62 52 Week Range 5.29
Previous Close
2.20
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
47,421
Financial Volume
-
VWAP
-

DWTX Latest News

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.23-9.465020576132.432.442.1174812.24972899CS
4-0.2202-9.098421618052.42022.99992.1269942.57615685CS
12-1.9-46.34146341464.15.151.62474213.00379923CS
26-1.35-38.02816901413.555.291.62768193.47635165CS
52-1.35-38.02816901413.555.291.62768193.47635165CS
156-1.35-38.02816901413.555.291.62768193.47635165CS
260-1.35-38.02816901413.555.291.62768193.47635165CS

DWTX - Frequently Asked Questions (FAQ)

What is the current Dogwood Therapeutics share price?
The current share price of Dogwood Therapeutics is US$ 2.20
What is the 1 year trading range for Dogwood Therapeutics share price?
Dogwood Therapeutics has traded in the range of US$ 1.62 to US$ 5.29 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 18.07
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 72.22
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.24
(0.00%)
0
AACGATA Creativity Global
US$ 1.03
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 18.07
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 72.22
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.24
(0.00%)
0
AACGATA Creativity Global
US$ 1.03
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 18.07
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 72.22
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.24
(0.00%)
0
AACGATA Creativity Global
US$ 1.03
(0.00%)
0

Your Recent History

Delayed Upgrade Clock